918625-33-9

Basic information

• Product Name: Z-3-(3-PyridinylMethyl)iMino-10β-piran-2-ol
• Synonyms: Z-3-(3-PyridinylMethyl)iMino-10β-piran-2-ol;(1R,2R,5R)-2,6,6-triMethyl-3-[(3-pyridinylMethyl)iMino]-bicyclo[3.1.1]heptan-2-ol
• CAS NO: 918625-33-9
• Molecular Formula: C16H22N2O
• Molecular Weight: 258.35868
• Product Categories: Aromatics;Heterocycles;Impurities;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 918625-33-9.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Room Temperature
• Solubility: Chloroform, Tetrahydrofuran, Toluene
• CAS DataBase Reference: Z-3-(3-PyridinylMethyl)iMino-10β-piran-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: Z-3-(3-PyridinylMethyl)iMino-10β-piran-2-ol(918625-33-9)
• EPA Substance Registry System: Z-3-(3-PyridinylMethyl)iMino-10β-piran-2-ol(918625-33-9)

Safety Data

• Hazardous Substances Data: 918625-33-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Z-3-(3-PyridinylMethyl)iMino-10β-piran-2-ol is used as an intermediate in the synthesis of various pharmaceutical compounds, particularly in the preparation of tobacco alkaloids. Its unique structure and properties contribute to the development of new drugs and therapeutic agents.
Used in Chemical Industry:
Z-3-(3-PyridinylMethyl)iMino-10β-piran-2-ol is used as a key component in the preparation of tobacco alkaloids, which are important in the production of certain chemical products and may have potential applications in research and development.

Upstream product

• 3731-52-0 3-Aminomethylpyridine 
• 1845-25-6 (+)-(2R)-2-hydroxy-3-pinanone 
• 1845-25-6 (-)-(2S)-2-hydroxy-3-pinanone 
• 10136-65-9 (1S,2S,5S,)-2-hydroxy-3-pinanone 
• 109-63-7 boron trifluoride diethyl etherate 

Relevant articles and documents

Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3. 2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands

(Chemical Equation Presented) In an attempt to generate nicotinic acetylcholine receptor (nAChR) ligands selective for the α4β2 and α7 subtype receptors we designed and synthesized constrained versions of anabasine, a naturally occurring nAChR ligand. 2-(

Pharmaceutical compositions and methods for effecting dopamine release

Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia), are treated by administering a 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, a 1-aza-2-(3-pyridyl)bicyclo[2.2.2]octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.1]octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.2]nonane, a 1-aza-7-(3-pyridyl) bicyclo[2.2.1]heptane, a 1-aza-3-(3-pyridyl)bicyclo[3.2.2]nonane, or a 1-aza-7-(3-pyridyl)bicyclo[3.2.2]nonane. The compounds can exist as individual stereoisomers, racemic mixtures, diastereomers and the like.